[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  GenExDividendInvestor [@GenExDividend](/creator/twitter/GenExDividend) on x 8248 followers Created: 2025-07-16 13:10:18 UTC Johnson & Johnson (4.49% of my portfolio is $JNJ) beats on non-GAAP EPS of $XXXX vs $XXXX and beats on revenue of $23.7B vs $22.86B and raises outlook. XXX engagements  **Related Topics** [jnj](/topic/jnj) [$2286b](/topic/$2286b) [$237b](/topic/$237b) [eps](/topic/eps) [$jnj](/topic/$jnj) [johnson johnson](/topic/johnson-johnson) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/GenExDividend/status/1945471053331075462)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
GenExDividendInvestor @GenExDividend on x 8248 followers
Created: 2025-07-16 13:10:18 UTC
Johnson & Johnson (4.49% of my portfolio is $JNJ) beats on non-GAAP EPS of $XXXX vs $XXXX and beats on revenue of $23.7B vs $22.86B and raises outlook.
XXX engagements
Related Topics jnj $2286b $237b eps $jnj johnson johnson stocks healthcare
/post/tweet::1945471053331075462